
Lithium
Side Effects
Short-Term
CNS: Sedation, confusion, unsteadiness, tremors, dysarthria, seizures (toxicity)
Neuromuscular: Rigidity, hyperreflexia
GI: Nausea, vomiting, diarrhoea
Cardiovascular: QTc prolongation, hypovolaemia (from nephrogenic diabetes insipidus)
Other: Psoriasis flares
Long-Term
Chronic lithium toxicity
Nephrogenic diabetes insipidus (NDI)
Hypothyroidism
Hyperparathyroidism
Weight gain
____________________________________
Toxicity
Toxic Doses/Levels
Acute: >5 g or serum >5 mmol/L
Chronic: Serum >1.5 mmol/L increases risk
Risk Factors
Dehydration
ACE inhibitors, ARBs, NSAIDs, diuretics (↓ renal clearance)
Hypothyroidism, CKD
Key Investigations
Serum Lithium: Serial 6-hourly levels
Renal Function: Creatinine, urea
Serum Sodium: Check for hypernatraemia (due to NDI)
ECG: QTc prolongation or arrhythmias
____________________________________
Monitoring on Treatment
Lithium Levels: Every 3–6 months (therapeutic range: 0.6–1.0 mmol/L; mania: 0.8–1.2 mmol/L)
Renal Function & Electrolytes (UEC, CMP): Regularly
TFTs: Every 6–12 months
Management of Toxicity
Acute Toxicity
Stop Lithium Immediately
Hydration: IV 0.9% NaCl to enhance elimination
Monitoring:
ECG
Serum lithium concentration
Renal function
Haemodialysis (consult toxicologist if):
Serum lithium >4 mmol/L + renal impairment
Serum lithium >5 mmol/L
Severe neurotoxicity (seizures, coma)
Decontamination
Activated charcoal ineffective (doesn’t bind lithium)
Consider whole-bowel irrigation if >50 g ingested within 4 hrs (toxicologist guidance)
Haemodialysis
Continue until serum lithium <1 mmol/L + clinical improvement
Additional Notes
CMP: Monitor calcium for hyperparathyroidism
Avoid medications that reduce renal clearance (ACE inhibitors, ARBs, NSAIDs, diuretics)
Bookmark Failed!
Bookmark Saved!